目的:探讨载脂蛋白B/载脂蛋白A1比值(APO B/APO A1)、血浆纤维蛋白原(FIB)水平与冠心病患者冠脉病变程度相关性。方法:选取冠心病患者152例,对照组69例,分别测定其APO B/APO A1比值、FIB水平,比较两组结果并分析其与冠状动脉病变程度的关系。结果:冠心病患者的APO B/APO A1比值、FIB水平均明显高于对照组(P < 0.05)。多支病变组APO B/APO A1比值、FIB水平明显高于单支病变组(P < 0.05)。Gensini评分重度组APO B/APO A1比值显著高于轻度组,差异具有统计学意义(P < 0.05)。FIB在Gensini评分重度组和轻度组中差异无统计学意义。在相关性分析中,冠心病患者中APO B/APO A1比值、FIB与Gensini评分均显著正相关(r = 0.266,0.372,P均<0.05)。结论:APO B/APO A1比值、FIB水平的升高与冠心病的发生及冠脉病变程度具有相关性。
Objective: To explore the correlation between the levels of apolipoprotein B/apolipoprotein A1 (APO B/APO A1) and plasma fibrinogen (FIB) and the degree of coronary artery disease in patients with coronary heart disease. Methods: A total of 152 patients with coronary heart disease and 69 patients in the control group were selected. The levels of APO B/APO A1 and FIB were measured respectively. The results of the two groups were compared and their relationship with the degree of coronary artery disease was analyzed. Results: The levels of APO B/APO A1 and FIB in patients with coronary heart disease were significantly higher than those in the control group (P < 0.05). The APO B/APO A1 and FIB in the multi-vessel disease group were significantly higher than that in the single-vessel disease group (P < 0.05). Gensini score in severe group APO B/APO A1 was significantly higher than mild group, the difference was statistically significant (P < 0.05). FIB had no statistically significant difference between the severe and mild groups of Gensini score. In the correlation analysis, APO B/APO A1, FIB and Gensini scores in patients with coronary heart disease were significantly positively correlated (r = 0.266, 0.372, P < 0.05). Conclusion: The increase of APO B/APO A1 and FIB levels is related to the occurrence of coronary heart disease and the degree of coronary artery disease.
Hashemi, M., Jervekani, Z.T., Mortazavi, S., et al. (2018) Association between Cognitive Function and Parameters of Echocar-diograPhy and Coronary Artery angiograPhy. Arquivos de Neuro-Psiquiatria, 76, 225-230.
https://doi.org/10.1590/0004-282x20180026
[3]
Tian, M., Li, R., Shan, Z., et al. (2019) Comparison of Apolipoprotein B/A1 Ratio, Framingham Risk Score and TC/HDL-c for Predicting Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention. Lipids in Health and Disease, 18, 47-68. https://doi.org/10.1186/s12944-019-1144-y
[4]
Song, Y., Yang, Y., Zhang, J., et al. (2015) The apoB100/apoAI Ratio Is Independently Associated with the Severity of Coronary Heart Disease: A Cross Sectional Study in Patients Undergoing Coronary Angiography. Lipids in Health and Disease, 14, 150. https://doi.org/10.1186/s12944-015-0155-6
Loeffen, R., van Oerle, R., Leers, M.P., et al. (2016) Factor XIa and Thrombin Generation Are Elevated in Patients with Acute Coronary Syndrome and Predict Recurrent Cardiovascular Events. PLoS ONE, 11, e0158355.
https://doi.org/10.1371/journal.pone.0158355
[7]
Tabakc, M.M., Gerin, F., Sunbul, M., et al. (2017) Relation of Plasma Fibrinogen Level with the Presence, Severity, and Complexity of Coronary Artery Disease. Clinical and Applied Thrombosis/Hemostasis, 23, 638-644.
https://doi.org/10.1177/1076029616629210